Steps toward therapeutically targeting the activin type II receptor for treating heart failure. Am J Physiol Heart Circ Physiol 2020 Feb 01;318(2):H326-H328
Date
01/11/2020Pubmed ID
31922889Pubmed Central ID
PMC7052619DOI
10.1152/ajpheart.00004.2020Scopus ID
2-s2.0-85078814455 (requires institutional sign-in at Scopus site) 2 CitationsAuthor List
Paddock SJ, O'Meara CCAuthor
Caitlin C. O'Meara PhD Associate Professor in the Physiology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Activin ReceptorsActivins
Fibrosis
Heart Failure
Humans
Ventricular Remodeling
